Table 2. Risk of recurrent wheezing and hospital readmission after acute bronchiolitis.
Azithromycin Group - Placebo Group (%) | RR (CI) | P- value | |
---|---|---|---|
3st month (wheezing) | 19.1-39.5 | 0.48 (0.24-0.98) | 0.038 |
3st month (readmission) | 8.5-10.5 | 0.80 (0.21-3.02) | 0.752 |
6st month (wheezing) | 25.6-27.3 | 0.93 (0.44-1.99) | 0.868 |
6st month (readmission) | 9.3-3.0 | 3.07 (0.36-26.2) | 1.274 |
RR: Relative Risk; CI: Confidence Interval; p-value: significance level (probability of obtaining test results as extreme as the results observed).